Skip to main content

$0.007 (0.00%)










30 June 2023 at 4:10pm
Register to track ME1 and receive email alerts.

Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Expand Company Description

Market Cap (20-May)

$845,610 (0th)

Close (30-Jun)


Volume (30-Jun)


Shortsold (10-May)

17,723 (0.00%) (601st)

52w High


52w Low






Appendix 2A


416,823 posts

ME1 released this announcement to the ASX on 15 June 2023, 18:36. The announcement is not marked as price sensitive, and is 22 page(s) in length and 559.89kb in size.

You can view all announcements from ME1 and see how they appear on a price chart on the announcements page.

At the date of this announcement, ME1 was 0.063% short sold according to ASIC data. It was ranked the 500th most shorted stock on the ASX. It remains ranked 601st as of the latest reported data (10 May 2024).

Other Recent Announcements from ME1
Appendix 3G 30 June 2023, 19:03
Appendix 2A 30 June 2023, 19:01
Appendix 2A 26 June 2023, 19:02
Appendix 2A 15 June 2023, 18:36
Disclosure Document 15 June 2023, 15:33
Appendix 3B 14 June 2023, 15:49
Appendix 2A 14 June 2023, 15:48

ME1 was $0.009 at the close of trade on 15 June 2023, it is now $0.002 (17.65%) lower

You must login or register to post a comment.

You must be logged in to post a reply.

Register to track ME1 and receive email alerts.